Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety

References

• GINA Report. Global strategy for asthma management and prevention. Revised 2010. Available at: http://www.ginaasthma.org. Accessed October 4, 2011.
   Google Scholar
• Murphy DM, O’Byrne PM. Recent advances in the pathophysiology of asthma. Chest 2010; 137(6):1417–1426.
   PubMed Web of Science ®Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. Global burden of asthma, a report for the Global Initiative for Asthma 2004. Available at: http://www.ginaasthma.org. Accessed October 4, 2011.
   Google Scholar
• Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996; 9(4):636–642.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O’Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteroids establishing therapy (FACET) International Study Group. N Engl J Med 1997; 337(20):1405–1411.
   PubMed Web of Science ®Google Scholar
• Naedele-Risha R, Dorinsky P, Craig TJ. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting β-agonists with inhaled corticosteroids. J Am Osteopath Assoc 2001; 101(9):526–533.
   PubMedGoogle Scholar
• Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344(8917):219–224.
   PubMed Web of Science ®Google Scholar
• Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1997; 153(5):1481–1488.
   Web of Science ®Google Scholar
• O’Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001; 164(8 Pt 1):1392–1397.
   PubMed Web of Science ®Google Scholar
• Thomas M, von Ziegenweidt J, Lee AJ, Price D. High-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma: an observational study. J Allergy Clin Immunol 2009; 123(1):116–121.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids. Eur Respir J 2002; 19(1): 182–191.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Scientific rationale for using a single inhaler for asthma control. Eur Respir J 2007; 29(3):587–595.
   PubMed Web of Science ®Google Scholar
• Marceau C, Lemière C, Berbiche D, Perreault S, Blais L. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol 2006; 118(3):574–581.
   PubMed Web of Science ®Google Scholar
• Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M, Pirina P, Carrozzi L, Dallari R, De Togni A, de Marco R. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 2006; 141(2):189–198.
   PubMed Web of Science ®Google Scholar
• Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani M, Carolei A, Cerveri I, Duran-Tauleria E, Gislason D, Gulsvik A, Jõgi R, Marinoni A, Martínez-Moratalla J, Vermeire P, de Marco R. Therapy and Health Economics Group of the European Community Respiratory Health Survey. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007; 120(6): 1360–1367.
   PubMed Web of Science ®Google Scholar
• Demoly P, Gueron B, Annunziata K, Adamek L, Walters RD. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010; 19(116):150–157.
   PubMedGoogle Scholar
• Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6:13.
   PubMedGoogle Scholar
• Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114(6):1288–1293.
   PubMed Web of Science ®Google Scholar
• Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003; 16(3):249–254.
   PubMedGoogle Scholar
• Kavuru M, Melamed J, Gross G, LaForce C, Hourse K, Prillaman B, Baitinger L, Woodring A, Shah T. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000; 105(6 pt 1):1108–1116.
   PubMed Web of Science ®Google Scholar
• Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O’Connor BJ. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5’-monophosphate in mild asthma. J Allergy Clin Immunol 2002; 110(4):603–606.
   PubMed Web of Science ®Google Scholar
• Luijk B, Kempsford RD, Wright AM, Zanen P, Lammers JW. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchocontriction. Eur Respir J 2004; 23(4):559–564.
   PubMed Web of Science ®Google Scholar
• Adams NP, Bestall JC, Jones P, Lasserson TJ, Griffiths B, Cates CJ. Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Systematic Reviews 2009, Issue 4. Art. No.: CD003534. DOI: 10.1002/14651858.CD003534.pub3.
   Google Scholar
• Adams NP, Bestall JC, Lasserson TJ, Jones P, Cates CJ. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Systematic Reviews 2009, Issue 4. Art. No.: CD003135. DOI: 10.1002/14651858.CD003135.pub4.
   Google Scholar
• Berger WE. The use of inhaled formoterol in the treatment of asthma. Ann Allergy Asthma Immunol 2006; 97(1):24–33.
   PubMed Web of Science ®Google Scholar
• Politiek MJ, Boorsma M, Aalbers R. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction. Eur Respir J 1999; 13(5):988–992.
   PubMed Web of Science ®Google Scholar
• Palmqvist M, Arvidsson P, Beckman O, Peterseon S, Lötvall J. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther 2001; 14(1): 29–34.
   PubMed Web of Science ®Google Scholar
• Lötvall J, Ankerst J. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients. Respir Med 2008; 102(3): 449–456.
   PubMed Web of Science ®Google Scholar
• Symbicort® Turbohaler® 200/6. Inhalation powder (AstraZeneca UK Ltd). Summary of product Characteristics 2011. Available at: http://www.medicines.org.uk. Accessed October 4, 2011.
   Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J 1993; 16(Suppl):5–40.
   Web of Science ®Google Scholar
• Quanjer PH, Borsboom GJ, Brunekreef B, Zach M, Forche G, Cotes JE, Sanchis J, Paoletti P. Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol 1995; 19(2):135–142.
   PubMed Web of Science ®Google Scholar
• Marks GB, Dunn SM, Woolcock AJ. An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. J Clin Epidemiol 1993; 46(10):1103–1111.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE, . American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American thoracic society/European respiratory society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180(1):59–99.
   PubMed Web of Science ®Google Scholar
• Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007; 29(4):682–689.
   PubMed Web of Science ®Google Scholar
• Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C, Ho SY, House K, Dorinsky P. Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma. J Asthma 2004; 41(8):797–806.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Huchon G, Leclerc V, Vicaut E, Lefrançois G. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (AerolizerTM) and placebo (pMDI or AerolizerTM™) in asthmatic patients. Respiration 2005; 72(Suppl 1):6–12.
   PubMedGoogle Scholar
• Edwards SJ, Gruffydd-Jones K, Ryan DP. Systematic review and meta-analysis of budesonide/formoterol in a single inhaler. Curr Med Res Opin 2007; 23(8):1809–1820.
   PubMed Web of Science ®Google Scholar
• Huchon G, Magnussen H, Chuchalin A, Dymek L, Bonnet Gonod F, Bousquet J. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med 2009; 103(1):41–49.
   PubMed Web of Science ®Google Scholar
• Palmqvist M, Ibsen T, Mellén A, Lötvall J. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients. Am J Respir Crit Care Med 1999; 160(1):244–249.
   PubMed Web of Science ®Google Scholar
• Bodzenta-Lukaszyk A, Pulka G, Dymek A, Bumbacea D, McIver T, Schwab B, Mansikka H. Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. Respir Med 2011; 105(5):674–682.
   PubMed Web of Science ®Google Scholar
• Bodzenta-Lukaszyk A, Dymek A, McAulay K, Mansikka H. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulm Med 2011; 11(1):28–38.
   PubMed Web of Science ®Google Scholar
• van der Palen J, Klein JJ, van Herwaarden CLA, Zielhuis GA, Seydel ER. Multiple inhalers confuse asthma patients. Eur Respir J 1999; 14(5):1034–1037.
   PubMed Web of Science ®Google Scholar